Evidence map›Paper›PMID 36142909›Full record

ArticleJournal of clinical medicine2022

Randomized Double-Blind Crossover Study for Evaluating a Probiotic Mixture on Gastrointestinal and Behavioral Symptoms of Autistic Children.

Cristina Guidetti, Elena Salvini, Maurizio Viri, Francesca Deidda, Angela Amoruso, Annalisa Visciglia, Lorenzo Drago, Matteo Calgaro, Nicola Vitulo, Marco Pane and 1 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. The Effect of Probiotics and Microbiota on Nervous System and Mental Illnesses.Central nervous system agents in medicinal chemistry · 2025
    Review
  15. Frontiers in microbiology · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cristina GuidettiDepartment of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.
Elena SalviniDepartment of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.
Maurizio ViriDepartment of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.
Francesca DeiddaProbiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.
Angela AmorusoProbiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.
Annalisa ViscigliaProbiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.ORCID 0000-0001-7621-6842
Lorenzo DragoDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.ORCID 0000-0002-5206-540X
Matteo CalgaroDepartment of Biotechnology, University of Verona, 37100 Verona, Italy.ORCID 0000-0002-3056-518X
Nicola VituloDepartment of Biotechnology, University of Verona, 37100 Verona, Italy.ORCID 0000-0002-9571-0747
Marco PaneProbiotical Research Srl, Via E. Mattei 3, 28100 Novara, Italy.ORCID 0000-0003-3575-6919
Anna Claudia CaucinoDepartment of Child Neuropsychiatry, University Hospital Maggiore della Carità, 28100 Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorders (ASDs) represent a diagnostic challenge with a still partially uncertain etiology, in which genetic and environmental factors have now been assessed. Among the hypotheses underlying the involvement of biological and environmental factors, the gut-brain axis is of particular interest in autism spectrum disorders. Several studies have highlighted the related incidence of particular gastrointestinal symptoms (GISs) in children suffering from ASDs. Probiotics have shown success in treating several gastrointestinal dysbiotic disorders; therefore, it is plausible to investigate whether they can alleviate behavioral symptoms as well. On these bases, a randomized double-blind crossover study with a placebo was conducted, evaluating the effects of a mixture of probiotics in a group of 61 subjects aged between 24 months and 16 years old with a diagnosis of ASD. Behavioral evaluation was performed through the administration of a questionnaire including a Parenting Stress Index (PSI) test and the Vineland Adaptive Behavior Scale (VABS). The Psycho-Educational Profile and the Autism Spectrum Rating Scale (ASRS) were also evaluated. Microbial composition analyses of fecal samples of the two groups was also performed. The study showed significant improvements in GISs, communication skills, maladaptive behaviors, and perceived parental stress level after the administration of probiotics. Microbiome alpha diversity was comparable between treatment arms and no significant differences were found, although beta diversity results were significantly different in the treatment group between T0 and T1 time points.

Indexed as

ASDautism spectrum disorderautistic childrenbehavioral symptomsgastrointestinal symptomsgut–brain axismicrobiome analysismicrobiotaprobioticsrandomized double-blind crossover study

Identifiers

PMID36142909
PMCPMC9504504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.